Post-exposure prophylaxis with monoclonal antibodies may reduce health system burden in the US

By | September 6, 2021
In a study conducted at the University of Washington, USA, the researchers assert that post-exposure prophylaxis with monoclonal antibodies could improve the clinical outcomes and health system costs regarding coronavirus disease (COVID-19). The study is currently available on the medRxiv* preprint server.